AbbVie Already Dividend King? Why Apogee Deal Could Cement a Dynasty
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Learn when to select cash back over rewards cards for optimal benefits. Make informed credit choices now!
26,510 articlesAbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
A Trump-linked figure renews a $1 million bitcoin target at the World Liberty Forum, reigniting debate as ETF flow an...
New surveys in 2026 reveal mounting retirement worries: only about a quarter of Americans feel prepared, while the ty...
In 2026, the Social Security earnings test can quietly trim benefits for those who work before full retirement age. T...
The SEC has postponed the draft innovation exemption for tokenized stocks, signaling a longer path to allowing tradin...
NUKZ is in focus as two pivotal drivers could redefine its trajectory: big-hyperscaler nuclear agreements and the rol...
Thematic ETFs promise big trends, but they come with concentration and timing risks. This guide breaks down when they...
When high-growth fintech names stumble, markets react quickly. This piece breaks down Klarna’s Q4 miss, the stock mov...
Bitcoin has seen wild swings, but could it really go to zero? This guide breaks down probabilities, failure scenarios...
Account takeovers threaten every investor. This guide breaks down what customer account takeovers: what they mean for...
Cisco stock has surged about 32% in the past 30 days as AI infrastructure demand climbs; Arista slid 10% and Broadcom...
Honda Motor Co. announced a nationwide recall covering about 880,000 vehicles due to a suspected rear suspension prob...